Copyright: ©Author(s) 2026.
World J Hepatol. Jul 27, 2026; 18(7): 116709
Published online Jul 27, 2026. doi: 10.4254/wjh.116709
Published online Jul 27, 2026. doi: 10.4254/wjh.116709
Table 1 Comparative strategic utility of magnetic resonance imaging-functional liver imaging score vs contrast-enhanced ultrasound
| Modality | Parameter | Strategic strength | Clinical constraint |
| MRI-Functional Liver Imaging Score | Uptake (organic anion-transporting polypeptides), excretion (multidrug resistance associated protein 2), and portal flow | Comprehensive assessment of cellular health and reserve[2,4,21] | High cost; inter-scanner variability; renal contraindications[6,8] |
| MRI-hepatic enhancement | Segment VI quantitative signal intensity | Objective and continuous metric; strong mortality predictor[1] | Logistical complexity; manual regions of interest placement; single-center limits[1] |
| Contrast-enhanced ultrasound | Hepatic vein arrival time and transit times | Real-time microvascular profiling; bedside-ready; low cost[10,15,18] | Operator-dependent; no hepatocyte-specific phase[19,20] |
- Citation: Giangregorio F. Prognostic power of dynamic enhancement in advanced chronic liver disease: Moving beyond static liver structure. World J Hepatol 2026; 18(7): 116709
- URL: https://www.wjgnet.com/1948-5182/full/v18/i7/116709.htm
- DOI: https://dx.doi.org/10.4254/wjh.116709